Improving tuberculosis treatment through community pharmacies in Uganda.

Integrating tuberculosis treatment into community pharmacies to improve TB/HIV outcomes in Uganda.

['FUNDING_OTHER'] · INFECTIOUS DISEASES INSTITUTE · NIH-10995251

This study is looking to improve how people with HIV in Uganda get treated for tuberculosis by making TB medications more accessible through local pharmacies, so they can receive better care and have a higher chance of recovery.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorINFECTIOUS DISEASES INSTITUTE (nih funded)
Locations1 site (KAMPALA, UGANDA)
Trial IDNIH-10995251 on ClinicalTrials.gov

What this research studies

This research aims to enhance tuberculosis (TB) treatment outcomes for individuals living with HIV in Uganda by integrating TB treatment services into community pharmacies. The approach focuses on addressing barriers to effective prevention, diagnosis, and treatment through person-centered strategies that are relevant to the local context. By leveraging community pharmacies, the project seeks to improve access to medications, enhance adherence to treatment, and ultimately increase the success rates of TB treatment among this vulnerable population.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living with HIV who are also diagnosed with tuberculosis.

Not a fit: Patients who do not have HIV or tuberculosis may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly improve TB treatment outcomes for people living with HIV in Uganda.

How similar studies have performed: Previous research has shown success in using community pharmacies to improve access to antiretroviral therapy, suggesting a promising approach for TB treatment as well.

Where this research is happening

KAMPALA, UGANDA

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.